HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wieslawa Bednarek Selected Research

CD34 Antigens (CD34 Antigen)

1/2013Microtissue density prognostic factor evaluation based on antigens CD34 and CD 105 in ovarian cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wieslawa Bednarek Research Topics

Disease

5Neoplasms (Cancer)
06/2015 - 12/2008
2Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 01/2011
1Neoplasm Metastasis (Metastasis)
02/2022
1Meigs Syndrome (Meig's Syndrome)
06/2015
1Cystadenocarcinoma
01/2011
1Carcinoma (Carcinomatosis)
01/2011
1Serous Cystadenoma
01/2011
1Serous Cystadenocarcinoma
01/2011
1Mucinous Cystadenocarcinoma
01/2011
1Endometriosis
03/2009
1Leiomyoma (Uterine Fibroids)
03/2009
1Fetal Death
12/2008
1Stillbirth
12/2008

Drug/Important Bio-Agent (IBA)

2AntigensIBA
06/2015 - 12/2008
1Tumor Biomarkers (Tumor Markers)IBA
06/2015
1Proteins (Proteins, Gene)FDA Link
06/2015
1AntibodiesIBA
01/2013
1ParaffinIBA
01/2013
1CD34 Antigens (CD34 Antigen)IBA
01/2013
1Chemokine CCL5IBA
01/2011
1HLA-G Antigens (HLA G)IBA
03/2009
1Oxytocin (Pitocin)FDA LinkGeneric
12/2008
1ProstaglandinsIBA
12/2008

Therapy/Procedure

1Lymph Node Excision (Lymph Node Dissection)
02/2022
1Laparotomy
03/2009
1Induced Labor
12/2008